Global Anaesthesia Drugs Market 2019-2029

Global Anaesthesia Drugs Market 2019-2029

The global anaesthesia drugs market is expected to reach $11.8bn in 2024 and is estimated to grow at a CAGR of 3.9% from 2019-2024. The local anaesthesia segment accounted for the largest share in the anaesthesia drugs market in 2018.

How this report will benefit you

Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 241-page report you will receive 129 tables and 117 figures– all unavailable elsewhere.

The 241-page report provides clear detailed insight into the global anaesthesia drugs market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand new report today you stay better informed and ready to act.

Report Scope

  • Global Anaesthesia Drugs Market forecasts from 2019-2029
  • Along with revenue prediction for the overall world market for anaesthesia drugs market, our investigation shows forecasts to 2029 for the market segmented by type:
  • Local Anaesthesia Drugs
  • General Anaesthesia Drugs
  • This report also provides revenue forecast to 2029 for these local anaesthesia drugs:
  • Benzocaine
  • Bupivacaine
  • Chloroprocaine
  • Lidocaine
  • Prilocaine
  • Ropivacaine
  • Others
  • This report also provides revenue forecast to 2029 for these general anaesthesia drugs:
  • Desflurane
  • Dexmedetomidine
  • Midazolam
  • Propofol
  • Remifentanil
  • Sevoflurane
  • Others
  • This report shows forecasts to 2029 for the market segmented by route of administration:
  • Inhalation Anaesthesia Drugs
  • Intravenous Anaesthesia Drugs
  • Topical Anaesthesia Drugs
  • Our analyses show individual revenue forecasts to 2029 for these regional and national markets:
  • North America: US and Canada
  • Europe: Germany, UK, France, Italy, Spain, Rest of Europe
  • Asia-Pacific: Japan, China, India, Rest of Asia-Pacific
  • RoW: Brazil, Mexico, Russia, South Africa
Each regional and national market is further segmented by type, drug and route of administration.
  • This report discusses these selected leading companies:
  • Baxter International, Inc.
  • AbbVie
  • PAION AG
  • Pfizer
  • Hameln Pharmaceuticals
  • AstraZeneca
  • Fresenius Kabi
  • Maruishi Pharmaceuticals
  • Pacira Pharmaceuticals, Inc
Depending on data availability, we provide for each company: a company overview, financial information, recent development, product portfolio and a SWOT analysis.
  • This report discusses promising drug candidates which are under development for the anaesthesia drugs market.
  • Our study discusses trends as well as factors that drive and challenge the anaesthesia drugs market.
Visiongain’s study is intended for anyone requiring commercial analyses for the anaesthesia drugs market. You find data, trends and predictions.

Please Note: Prior to initiating fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.

The publisher is using a password system to access all reports. Single user (non-printable) and departmental licenses expires after 12 month period. In the case of departmental site license purchases, the publisher requires all email addresses for the licensed users prior to fulfillment.


1. Report Overview
1.1 Why You Should Read This Report
1.2 How This Report Delivers
1.3 Key Questions Answered by This Analytical Report Include:
1.4 Who is This Report For?
1.5 Methodology
1.5.1 Primary Research
1.5.2 Secondary Research
1.5.3 Market Evaluation & Forecasting Methodology
1.6 Frequently Asked Questions (FAQ)
1.7 Associated Visiongain Reports
1.8 About Visiongain
2. Introduction to Anaesthetic Drugs
2.1 What is an Anaesthesia?
2.1.1 Types of Anaesthetics
2.1.1.1 General Anaesthetics
2.1.1.2 Local Anaesthetics
2.1.1.3 Sedation
2.2 What are the Risk and Side Effects of Anaesthesia Drugs?
2.2.1 Localized side effects
2.2.2 General side effects
2.3 Epidemiology of Anaesthetic Drugs
2.4 Humanistic and Economic Burden
2.4.1 Mortality
2.4.2 Morbidity
2.4.3 Economic Impact
3. Introduction to the Global Anaesthesia Drugs Market
4. Global Anaesthesia Drugs Market Forecast 2019-2029
5. Global Anaesthesia Drugs Market Forecast by Type, 2019-2029
5.1 Global Local Anaesthesia Drugs Market 2019-2029
5.2 Global General Anaesthesia Drugs Market 2019-2029
6. Global Anaesthesia Drugs Market Forecast by Routes of Administration, 2019-2029
6.1 Global Inhalation Anaesthesia Drugs Market 2019-2029
6.2 Global Intravenous Anaesthesia Drugs Market 2019-2029
6.3 Global Topical Anaesthesia Drugs Market 2019-2029
7. Global Anaesthesia Drugs by Regional and National Markets, 2019-2029
7.1 Anaesthesia Drugs Market by Region, 2018
7.2 North America Anaesthesia Drugs Market
7.2.1 North America Anaesthesia Drugs Market Forecast 2019-2029
7.2.2 North America Anaesthesia Drugs Market Forecast by Country, 2019-2029
7.2.3 North America Anaesthesia Drugs Market Forecast by Type, 2019-2029
7.2.4 North America Anaesthesia Drugs Market Forecast by Route of Administration, 2019-2029
7.2.5 U.S. Anaesthesia Drugs Market Forecast by Route of Administration, 2019-2029
7.2.6 Canada Anaesthesia Drugs Market Forecast by Route of Administration, 2019-2029
7.3 Europe Anaesthesia Drugs Market
7.3.1 Europe Anaesthesia Drugs Market Forecast 2019-2029
7.3.2 Europe Anaesthesia Drugs Market Forecast by Country, 2019-2029
7.3.3 Europe Anaesthesia Drugs Market Forecast by Type, 2019-2029
7.3.4 Europe Anaesthesia Drugs Market Forecast by Route of Administration, 2019-2029
7.3.5 Germany Anaesthesia Drugs Market Forecast by Route of Administration 2019-2029
7.3.6 UK Anaesthesia Drugs Market Forecast by Route of Administration 2019-2029
7.3.7 France Anaesthesia Drugs Market by Route of Administration, 2019-2029
7.3.8 Italy Anaesthesia Drugs Market Forecast by Route of Administration, 2019-2029
7.3.9 Spain Anaesthesia Drugs Market Forecast by Route of Administration, 2019-2029
7.3.10 Rest of Europe Anaesthesia Drugs Market Forecast by Route of Administration, 2019-2029
7.4 Asia-Pacific Anaesthesia Drugs Market
7.4.1 Asia-Pacific Anaesthesia Drugs Market Forecast 2019-2029
7.4.2 Asia-Pacific Anaesthesia Market Forecast by Country, 2019-2029
7.4.3 Asia-Pacific Anaesthesia Drugs Market Forecast by Type, 2019-2029
7.4.4 Asia-Pacific Anaesthesia Drugs Market Forecast by Route of Administration, 2019-2029
7.4.5 Japan Anaesthesia Drugs Market Forecast by Route of Administration, 2019-2029
7.4.6 China Anaesthesia Drugs Market Forecast by Route of Administration, 2019-2029
7.4.7 India Anaesthesia Drugs Market Forecast by Route of Administration, 2019-2029
7.4.8 Rest of Asia-Pacific Anaesthesia Drugs Market Forecast by Route of Administration, 2019-2029
7.5 RoW Anaesthesia Drugs Market
7.5.1 RoW Anaesthesia Drugs Market Forecast 2019-2029
7.5.2 RoW Anaesthesia Drugs Market Forecast by Country, 2019-2029
7.5.3 RoW Anaesthesia Drugs Market Forecast by Type, 2019-2029
7.5.4 RoW Anaesthesia Drugs Market Forecast by Route of Administration, 2019-2029
7.5.6 Brazil Anaesthesia Market by Route of Administration, 2019-2029
7.5.7 Mexico Anaesthesia Drugs Market Forecast by Route of Administration, 2019-2029
7.5.8 Russia Anaesthesia Drugs Market Forecast by Route of Administration, 2017-2029
7.5.9 South Africa Anaesthesia Market Forecast by Route of Administration, 2017-2029
8. Leading Drugs in the Global Anaesthesia Drugs Market, 2018
8.1 Propofol (Diprivan)
8.2 Sevoflurane (Sojourn, Ultane)
8.3 Remifentanil
8.4 Midazolam
8.5 Lidocaine
8.6 Ropivacaine
9. Market Growth Drivers
9.1 Increasing incidence of surgeries
9.2 Increasing cosmetic surgeries
9.3 Designated ICD-10 Code
9.4 Demand for general anaesthesia drugs
9.5 Increased investment in R&D
9.6 Advancements in medical power supply products
9.7 Rise in Geriatric population
10. Market Challenges
10.1 Healthcare consolidation
10.2 Stringent Regulatory Guidelines
10.3 Paucity of large, prospective and collaborative outcome studies
11. Market Trends
11.1 Advances in modern technologies
11.2 Strategic alliances among key players in the market
11.3 Expansion of healthcare sector in developing countries due to growing investments by major players
11.4 Advancements in drug delivery methods
11.5 Paucity of new drugs to change the practice of operating room Anaesthesia
11.6 Expect improved safety statistics regarding anaesthesia mortality and morbidity
11.7 Rising trend of home healthcare
12. Pipeline Molecules
12.1 Promising Potential Pipeline Molecules
12.1.1 Phase IV Molecules
12.1.1.1 Exparel (Bupivacaine Liposome)
12.1.2 Phase III Molecules
12.1.2.1 Remimazolam (CNS 7056)
12.1.3 Phase I Molecules
12.1.3.1 Cyclopropyl-methoxycarbonyl metomidate (ABP-700)
12.1.3.2 Carboetomidate
12.1.3.3 JM-1232 (-) (MR04A3)
12.1.3.4 Propofol
12.1.3.5 PF0713
12.1.3.6 Fospropofol
12.1.3.7 AZD-3043 (TD4756)
13. Leading Companies in Global Anaesthetic Drugs Market, 2018
13.1 Baxter International Inc.
13.2 AbbVie Inc.
13.3 PAION AG
13.4 Pfizer Inc.
13.5 Hameln Pharmaceuticals Ltd.
13.6 AstraZeneca
13.7 Fresenius Kabi
13.8 Maruishi Pharmaceuticals
13.9 Pacira Pharmaceuticals Inc.
13.10 Hospira Inc. (Pfizer Inc.)
13.10.1. Hospira Inc.: Product Portfolio
13.10.2. Recent Developments
13.10.2.1 Sale of Hospira’s Medical Devices Business to Enhance Operating Efficiency
13.10.2.2 Pfizer Expands Manufacturing Capacity for Sterile Injectable
13.11 Sandoz International GmbH (Novartis A.G)
13.11.1. Sandoz (Novartis A.G): Product Portfolio
13.11.2. Sandoz (Novartis A.G): Recent Development
13.11.2.1 Launch of First Generic of Suprane, in the U.S. is likely to Foster Market Share
13.12 Piramal Critical Care Inc. (Piramal Group)
13.12.1. Piramal Critical Care Inc. (Piramal Group): Product Portfolio
13.12.2. Piramal Critical Care Inc.: Recent Development
13.12.2.1 Strategic Acquisition to Rapidly Expand Product Offerings
13.12.2.2 Launch of Desflurane in 2019
13.13 Mylan N.V.
13.13.1. Mylan N.V.: Product Portfolio
13.13.2. Mylan N.V.: Recent Development
13.13.2.1 Acquisition China Player to Expand Geographical Reach
13.14 Aurobindo Pharma
13.14.1. Aurobindo Pharma: Product Portfolio
13.14.2. Aurobindo Pharma: Recent Developments
13.14.2.1 ANDA Approval
14. Conclusions
Visiongain Report Sales Order Form
Associated Visiongain Reports
About Visiongain
Visiongain report evaluation form
List of Tables
Table 2.1 Type of Surgeries performed in 2010 and 2020 (%)
Table 4.1 Global Anaesthesia Drugs Market 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 4.2 Global Anaesthesia Drugs Market by Regional Market Forecast 2019-2029 ($bn, AGR %, Cumulative)
Table 4.3 Global Anaesthesia Drugs Market Forecast by Country 2019-2029 ($bn, AGR %, Cumulative)
Table 5.1 Global Local Anaesthesia Drugs Market 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 5.2 Global Local Anaesthesia Drugs Market by Drug, 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 5.3 Global General Anaesthesia Drugs Market 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 5.4 Global General Anaesthesia Drugs Market by Drug, 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 6.1 Global Inhalation Anaesthesia Drugs Market 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 6.2 Global Intravenous Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 6.3 Global Topical Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 7.1 North America Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 7.2 U.S. Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 7.3 Canada Anaesthesia Market Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 7.4 North America Local Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 7.5 North America Local Anaesthesia Drugs Market Forecast 2017-2029 by Drug: Revenue ($bn), AGR (%), CAGR (%)
Table 7.6 North America General Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 7.7 North America General Anaesthesia Drugs Market Forecast 2017-2029 by Drug: Revenue ($bn), AGR (%), CAGR (%)
Table 7.8 North America Inhalation Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 7.9 North America Intravenous Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 7.10 North America Topical Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 7.11 U.S. Inhalation Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 7.12 U.S. Intravenous Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 7.13 U.S. Topical Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 7.14 Canada Inhalation Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 7.15 Canada Intravenous Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 7.16 Canada Topical Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 7.17 Europe Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 7.18 Germany Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 7.19 UK Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 7.20 France Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 7.21 Italy Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 7.22 Spain Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 7.23 Rest of Europe Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 7.24 Europe General Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 7.25 Europe General Anaesthesia Drugs Market Forecast 2017-2029 by Drug: Revenue ($bn), AGR (%), CAGR (%)
Table 7.26 Europe Local Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 7.27 Europe Local Anaesthesia Drugs Market Forecast 2017-2029 by Drug: Revenue ($bn), AGR (%), CAGR (%)
Table 7.28 Europe Inhalation Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 7.29 Europe Intravenous Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 7.30 Europe Topical Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 7.31 Germany Inhalation Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 7.32 Germany Intravenous Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 7.33 Germany Topical Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 7.34 UK Inhalation Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 7.35 UK Intravenous Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 7.36 UK Topical Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 7.37 France Inhalation Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 7.38 France Intravenous Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 7.39 France Topical Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 7.40 Italy Inhalation Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 7.41 Italy Intravenous Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 7.42 Italy Topical Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 7.43 Spain Inhalation Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 7.44 Spain Intravenous Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 7.45 Spain Topical Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 7.46 Rest of Europe Inhalation Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 7.47 Rest of Europe Intravenous Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 7.48 Rest of Europe Topical Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 7.49 Asia-Pacific Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 7.50 Japan Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 7.51 China Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 7.52 India Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 7.53 Rest of Asia-Pacific Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 7.54 Asia-Pacific General Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 7.55 Asia Pacific General Anaesthesia Drugs Market Forecast 2017-2029 by Drug: Revenue ($bn), AGR (%), CAGR (%)
Table 7.56 Asia-Pacific Local Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 7.57 Asia Pacific Local Anaesthesia Drugs Market Forecast 2017-2029 by Drug: Revenue ($bn), AGR (%), CAGR (%)
Table 7.58 Asia-Pacific Inhalation Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 7.59 Asia-Pacific Intravenous Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 7.60 Asia-Pacific Topical Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 7.61 Japan Inhalation Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 7.62 Japan Intravenous Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 7.63 Japan Topical Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 7.64 China Inhalation Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 7.65 China Intravenous Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 7.66 China Topical Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 7.67 India Inhalation Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 7.68 India Intravenous Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 7.69 India Topical Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 7.70 Rest of Asia-Pacific Inhalation Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 7.71 Rest of Asia-Pacific Intravenous Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 7.72 Rest of Asia-Pacific Topical Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 7.73 RoW Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 7.74 Brazil Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 7.75 Mexico Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 7.76 Russia Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 7.77 South Africa Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 7.78 Rest of RoW Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 7.79 RoW Local Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 7.80 RoW Local Anaesthesia Drugs Market Forecast 2017-2029 by Drug: Revenue ($bn), AGR (%), CAGR (%)
Table 7.81 RoW General Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 7.82 RoW General Anaesthesia Drugs Market Forecast 2017-2029 by Drug: Revenue ($bn), AGR (%), CAGR (%)
Table 7.83 RoW Inhalation Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 7.84 RoW Intravenous Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 7.85 RoW Topical Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 7.86 Brazil Inhalation Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 7.87 Brazil Intravenous Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 7.88 Brazil Topical Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 7.89 Mexico Inhalation Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 7.90 Mexico Intravenous Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 7.92 Mexico Topical Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 7.92 Russia Inhalation Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 7.93 Russia Intravenous Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 7.94 Russia Topical Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 7.95 South Africa Inhalation Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 7.96 South Africa Intravenous Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 7.97 South Africa Topical Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%), CAGR (%)
Table 12.1 Active Pipeline Molecules under Development for Anaesthesia Drugs
Table 13.1 Baxter: Overview
Table 13.2 Baxter: Revenue ($m), Revenue Share (%) and AGR (%) Breakdown by Geographical Segment, 2016-2017
Table 13.3 AbbVie: Overview
Table 13.4 PAION AG: Overview
Table 13.5 Pfizer: Overview
Table 13.6 Hameln: Overview
Table 13.7 AstraZeneca: Overview
Table 13.8 Fresenius Kabi: Overview 2016
Table 13.9 Maruishi: Overview
Table 13.10 Pacira: Overview
Table 13.11 Hospira Inc.: Overview, 2017
Table 13.12 Hospira Inc.: Anaesthesia Drug Offerings
Table 13.13. Sandoz: Overview, 2017
Table 13.14. Sandoz.: Anaesthesia Drug Offerings
Table 13.15: Piramal Critical Care Inc.: Overview, 2017
Table 13.16. Piramal Critical Care Inc.: Anaesthesia Drug Offerings
Table 13.17: Mylan N.V.: Overview, 2017
Table 13.18: Mylan N.V..: Anaesthesia Drug Offerings
Table 13.19: Aurobindo Pharma: Overview, 2017
Table 13.20: Aurobindo Pharma: Anaesthesia Drug Offerings
List of Figures
Figure 4.1 Global Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%)
Figure 4.2 Global Anaesthesia Market by Region (%), 2017-2029
Figure 4.3 Global Anaesthesia Market by Type (%), 2017-2029
Figure 4.4 Global Anaesthesia Market by Route of Administration (%), 2017-2029
Figure 5.1 Global Local Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%)
Figure 5.2 Global Local Anaesthesia Drugs Market Forecast 2017-2029 by Drug: Revenue ($bn)
Figure 5.3 Global Local Anaesthesia Drugs Market by Drug in 2018 (%)
Figure 5.4 Global Local Anaesthesia Drugs Market by Drug in 2024 (%)
Figure 5.5 Global Local Anaesthesia Drugs Market by Drug in 2029 (%)
Figure 5.6 Global General Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%)
Figure 5.7 Global General Anaesthesia Drugs Market by Drug in 2018: Revenue ($bn)
Figure 5.8 Global General Anaesthesia Drugs Market by Drug in 2018 (%)
Figure 5.9 Global General Anaesthesia Drugs Market by Drug in 2024 (%)
Figure 5.10 Global General Anaesthesia Drugs Market by Drug in 2029 (%)
Figure 6.1 Global Intravenous Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%)
Figure 6.2 Global Topical Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%)
Figure 7.1 Anaesthesia Drugs Market by Region (% Share), 2018
Figure 7.2 Number of Inpatient Surgeries by Type in Canada, 2015-2016
Figure 7.3 North America Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%)
Figure 7.4 North America Anaesthesia Drugs Market Forecast by Country 2017-2029: Revenue ($bn)
Figure 7.5 North America Anaesthesia Drugs Market by Country: (% Share), 2018
Figure 7.6 North America Anaesthesia Drugs Market by Country: (% Share), 2024
Figure 7.7 North America Anaesthesia Drugs Market by Country: (% Share), 2029
Figure 7.8 North America Local Anaesthesia Drugs Market by Drug in 2018: Revenue ($bn)
Figure 7.9 North America Local Anaesthesia Drugs Market by Drug in 2018 (%)
Figure 7.10 North America Local Anaesthesia Drugs Market by Drug in 2024 (%)
Figure 7.11 North America Local Anaesthesia Drugs Market by Drug in 2029 (%)
Figure 7.12 North America General Anaesthesia Drugs Market by Drug in 2018: Revenue ($bn)
Figure 7.13 North America General Anaesthesia Drugs Market by Drug in 2018 (%)
Figure 7.14 North America General Anaesthesia Drugs Market by Drug in 2024 (%)
Figure 7.15 North America General Anaesthesia Drugs Market by Drug in 2029 (%)
Figure 7.16 North America Anaesthesia Drugs Market Forecast by Type 2017-2029: Revenue ($bn)
Figure 7.17 North America Anaesthesia Drugs Market by Type: (% Share), 2018
Figure 7.18 North America Anaesthesia Drugs Market by Type: (% Share), 2024
Figure 7.19 North America Anaesthesia Drugs Market by Type: (% Share), 2029
Figure 7.20 North America Anaesthesia Drugs Market Forecast by Route of Administration 2017-2029: Revenue ($bn)
Figure 7.21 North America Anaesthesia Drugs Market by Route of Administration: (% Share), 2018
Figure 7.22 North America Anaesthesia Drugs Market by Route of Administration: (% Share), 2024
Figure 7.23 North America Anaesthesia Drugs Market by Route of Administration: (% Share), 2029
Figure 7.24 Europe Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%)
Figure 7.25 Europe Anaesthesia Drugs Market Forecast by Country 2017-2029: Revenue ($bn)
Figure 7.26 Europe Anaesthesia Drugs Market by Country: (% Share), 2018
Figure 7.27 Europe Anaesthesia Drugs Market by Country: (% Share), 2024
Figure 7.28 Europe Anaesthesia Drugs Market by Country: (% Share), 2029
Figure 7.29 Europe General Anaesthesia Drugs Market by Drug in 2018: Revenue ($bn)
Figure 7.30 Europe General Anaesthesia Drugs Market by Drug in 2018 (%)
Figure 7.31 Europe General Anaesthesia Drugs Market by Drug in 2024 (%)
Figure 7.32 Europe General Anaesthesia Drugs Market by Drug in 2029 (%)
Figure 7.33 Europe Local Anaesthesia Drugs Market by Drug in 2018: Revenue ($bn)
Figure 7.34 Europe Local Anaesthesia Drugs Market by Drug in 2018 (%)
Figure 7.35 Europe Local Anaesthesia Drugs Market by Drug in 2024 (%)
Figure 7.36 Europe Local Anaesthesia Drugs Market by Drug in 2029 (%)
Figure 7.37 Europe Anaesthesia Drugs Market Forecast by Type 2017-2029: Revenue ($bn)
Figure 7.38 Europe Anaesthesia Drugs Market by Type: (% Share), 2018
Figure 7.39 Europe Anaesthesia Drugs Market by Type: (% Share), 2024
Figure 7.40 Europe Anaesthesia Drugs Market by Type: (% Share), 2029
Figure 7.41 Europe Anaesthesia Drugs Market Forecast by Route of Administration 2017-2029: Revenue ($bn)
Figure 7.42 Europe Anaesthesia Drugs Market by Route of Administration: (% Share), 2018
Figure 7.43 Europe Anaesthesia Drugs Market by Route of Administration: (% Share), 2024
Figure 7.44 Europe Anaesthesia Drugs Market by Route of Administration: (% Share), 2029
Figure 7.45 Asia-Pacific Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%)
Figure 7.46 Asia-Pacific Anaesthesia Drugs Market Forecast by Country 2017-2029: Revenue ($bn)
Figure 7.47 Asia-Pacific Anaesthesia Drugs Market by Country: (% Share), 2018
Figure 7.48 Asia-Pacific Anaesthesia Drugs Market by Country: (% Share), 2024
Figure 7.49 Asia-Pacific Anaesthesia Drugs Market by Country: (% Share), 2029
Figure 7.50 Asia Pacific General Anaesthesia Drugs Market by Drug in 2018 (%)
Figure 7.51 Asia Pacific General Anaesthesia Drugs Market by Drug in 2018 (%)
Figure 7.52 Asia Pacific General Anaesthesia Drugs Market by Drug in 2024 (%)
Figure 7.53 Asia Pacific General Anaesthesia Drugs Market by Drug in 2029 (%)
Figure 7.54 Asia Pacific Local Anaesthesia Drugs Market by Drug in 2018: Revenue ($bn)
Figure 7.55 Asia Pacific Local Anaesthesia Drugs Market by Drug in 2018 (%)
Figure 7.56 Asia Pacific Local Anaesthesia Drugs Market by Drug in 2024 (%)
Figure 7.57 Asia Pacific Local Anaesthesia Drugs Market by Drug in 2029 (%)
Figure 7.58 Asia-Pacific Anaesthesia Drugs Market Forecast by Type 2017-2029: Revenue ($bn)
Figure 7.59 Asia-Pacific Anaesthesia Drugs Market by Type: (% Share), 2018
Figure 7.60 Asia-Pacific Anaesthesia Drugs Market by Type: (% Share), 2024
Figure 7.61 Asia-Pacific Anaesthesia Drugs Market by Type: (% Share), 2029
Figure 7.62 Asia-Pacific Anaesthesia Drugs Market Forecast by Route of Administration 2017-2029: Revenue ($bn)
Figure 7.63 Asia-Pacific Anaesthesia Drugs Market by Route of Administration: (% Share), 2018
Figure 7.64 Asia-Pacific Anaesthesia Drugs Market by Route of Administration: (% Share), 2024
Figure 7.65 Asia-Pacific Anaesthesia Drugs Market by Route of Administration: (% Share), 2029
Figure 7.66 RoW Anaesthesia Drugs Market Forecast 2017-2029: Revenue ($bn), AGR (%)
Figure 7.67 RoW Anaesthesia Drugs Market Forecast by Country 2017-2029: Revenue ($bn)
Figure 7.68 RoW Anaesthesia Drugs Market by Country: (% Share), 2018
Figure 7.69 RoW Anaesthesia Drugs Market by Country: (% Share), 2024
Figure 7.70 RoW Anaesthesia Drugs Market by Country: (% Share), 2029
Figure 7.71 RoW Local Anaesthesia Drugs Market by Drug in 2018 (%)
Figure 7.72 RoW Local Anaesthesia Drugs Market by Drug in 2018 (%)
Figure 7.73 RoW Local Anaesthesia Drugs Market by Drug in 2024 (%)
Figure 7.74 RoW Local Anaesthesia Drugs Market by Drug in 2029 (%)
Figure 7.75 RoW General Anaesthesia Drugs Market by Drug in 2018: Revenue ($bn)
Figure 7.76 RoW General Anaesthesia Drugs Market by Drug in 2018 (%)
Figure 7.77 RoW General Anaesthesia Drugs Market by Drug in 2024 (%)
Figure 7.78 RoW General Anaesthesia Drugs Market by Drug in 2029 (%)
Figure 7.79 RoW Anaesthesia Drugs Market Forecast by Type 2017-2029: Revenue ($bn)
Figure 7.80 RoW Anaesthesia Drugs Market by Type: (% Share), 2018
Figure 7.81 RoW Anaesthesia Drugs Market by Type: (% Share), 2024
Figure 7.82 RoW Anaesthesia Drugs Market by Type: (% Share), 2029
Figure 7.83 RoW Anaesthesia Drugs Market Forecast by Route of Administration 2017-2029: Revenue ($bn)
Figure 7.84 RoW Anaesthesia Drugs Market by Route of Administration: (% Share), 2018
Figure 7.85 RoW Anaesthesia Drugs Market by Route of Administration: (% Share), 2024
Figure 7.86 RoW Anaesthesia Drugs Market by Route of Administration: (% Share), 202
Figure 13.1 Baxter: Revenue Share (%) Breakdown by Geographical Segment, 2017
Figure 13.2 Baxter: SWOT Analysis
Figure 13.3 AbbVie Inc.: Revenue Share (%) Breakdown by Product Segment, 2017
Figure 13.4 AbbVie Inc.: Revenue Share (%) Breakdown by Geographic Area, 2017
Figure 13.5 AbbVie Inc.: Sevoflurane Drug Revenue Share (%) Breakdown, 2017
Figure 13.6 AbbVie: SWOT Analysis
Figure 13.7 PAION AG: SWOT Analysis
Figure 13.8 AstraZeneca: SWOT Analysis
Figure 13.9 Fresenius Kabi: Revenue Share (%) Breakdown by Geographic Area, 2016-2017
Figure 13.10 Fresenius Kabi: Revenue Share (%) Breakdown by Product Segment, 2016-2017
Figure 13.11 Fresenius Kabi: SWOT Analysis
Figure 13.12 Maruishi Pharmaceuticals: SWOT Analysis
Figure 13.13 Pacira Pharmaceuticals: SWOT Analysis
Figure 14.1 Anaesthesia Market by Type (% share 2019 & 2029)
Figure 14.2 Anaesthesia Market by Route of Administration (% share 2019 & 2029)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook